Evidence map›Paper›PMID 32648046›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Serum level of lipoprotein-associated phospholipase A2 is a potential biomarker of vertebrobasilar dolichoectasia and its progression to cerebral infarction.

Yuan Liu, Jinhua Zhu, Xuhui Deng, Zhi Yang, Chunchun Chen, Shuxuan Huang, Lue Chen, Ying Ma, Weifeng Lin, Feiqi Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yuan Liu *Department of Neurology, The Affiliated Yue Bei People's Hospital of ShantouUniversity Medical College, Shaoguan, 512025, Guangdong, People's Republic of China.
Jinhua Zhu *Department of Neurology, The Affiliated Yue Bei People's Hospital of ShantouUniversity Medical College, Shaoguan, 512025, Guangdong, People's Republic of China.
Xuhui Deng *Department of Neurology, The Affiliated Yue Bei People's Hospital of ShantouUniversity Medical College, Shaoguan, 512025, Guangdong, People's Republic of China.
Zhi Yang *Department of Neurology, The Affiliated Yue Bei People's Hospital of ShantouUniversity Medical College, Shaoguan, 512025, Guangdong, People's Republic of China.
Chunchun Chen *Cognitive Impairment Ward of Neurology Department, the Third Affiliated Hospital of Shenzhen University Medical College, Shenzhen, 518001, Guangdong, People's Republic of China.
Shuxuan HuangDepartment of Neurology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, Guangxi, People's Republic of China.
Lue ChenDepartment of Neurology, Shunde Hospital of Southern Medical University, Shunde, Foshan, 528300, Guangdong, People's Republic of China.
Ying MaDepartment of Cardiology, The Third Affiliated Hospital of Shenzhen University Medical College, Shenzhen, 518001, Guangdong, People's Republic of China.
Weifeng LinDepartment of Psychiatry, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, Guangdong, China.
Feiqi ZhuDepartment of Neurology, The Affiliated Yue Bei People's Hospital of ShantouUniversity Medical College, Shaoguan, 512025, Guangdong, People's Republic of China. zfqzsu2004@aliyun.com.ORCID http://orcid.org/0000-0003-4704-8928
Shantou University · CNShenzhen University · CNFirst Affiliated Hospital of Jinan University · CNThe First People's Hospital of Shunde · CNThe People's Hospital of Guangxi Zhuang Autonomous Region · CN

Funding

Department of Education of Guangdong Province 201410560092Sanming Project of Medicine in Shenzhen SZSM201801014
6 · The paper itself

Abstract

backgroundThere are no effective therapies to prevent the occurrence and progression of vertebrobasilar dolichoectasia (VBD). In this study, we investigated the relationship between serum levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) and the occurrence and progression of VBD.

methodsSixty (60) cases without VBD and ischemia stroke were considered as Group A, 100 cases with VBD were further divided into Group B (VBD without ischemic stroke, n = 54) and Group C (VBD with first ever acute posterior circulation ischemic stroke, n = 46). Demographic data (such as gender and age) and past medical history (such as hypertension, diabetes, and smoking history) were collected. The levels of serum low-density lipoprotein cholesterol (LDL-C), hypersensitivity C reactive protein (hs-CRP), glycosylated hemoglobin (HbAlc), homocysteine (HCY), uric acid (UA), fibrinogen (Fib), and Lp-PLA2, etc. were measured. Logistic regression analysis was used to assess the related factors of VBD and ischemic stroke secondary to VBD.

resultsLogistic multivariate regression analysis showed that only age and the level of serum Lp-PLA2 were significantly higher in group B than those in group A (P < 0.012, P < 0.001, respectively), however, only the level of serum Lp-PLA2 was significantly higher in group C than those in group B (P < 0.001).

conclusionsThe serum marker Lp-PLA2 is an independent risk factor for the occurrence of VBD and the progression of VBD to posterior circulation ischemic stroke. Whether intervening on atherosclerosis could prevent the occurrence and development of VBD needs to be further studied.

Indexed as

1-Alkyl-2-acetylglycerophosphocholine EsteraseAtherosclerosisVertebrobasilar InsufficiencyBiomarkersCerebral InfarctionHumansRisk Factors1-Alkyl-2-acetylglycerophosphocholine EsteraseBiomarkersPLA2G7 protein, humanAtherosclerosisBiomarkerLipoprotein-associated phospholipase A2Vertebrobasilar dolichoectasia

Identifiers

PMID32648046
OpenAlexW3041139631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.